Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A review.
Journal: Neuro-oncology advances
Published: September 05, 2024
Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins.
Journal: medRxiv : the preprint server for health sciences
Published: March 22, 2023
GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity.
Journal: Nature cancer
Published: December 14, 2022
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.
Journal: Cancer discovery
Published: August 08, 2022
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.
Journal: Genes & development
Published: June 06, 2022
The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.
Journal: JCI insight
Published: March 09, 2022
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Journal: Scientific reports
Published: January 19, 2022
SerpinB3 drives cancer stem cell survival in glioblastoma.
Journal: Cell reports
Published: January 05, 2022
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets.
Journal: Cancer research
Published: November 09, 2021
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Journal: Scientific reports
Published: September 09, 2021
Last Updated: 09/26/2026